(NQ: )

N/A UNCHANGED

Last Price Updated: Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	31.99
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	N/A
Dividend Yield	N/A

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

NodThera secures £28 million ($40 million) Series A Financing

June 24, 2018

Relypsa Announces Data on the Treatment and Impact of Hyperkalemia to be Presented at ASN Kidney Week 2016

November 03, 2016

Relypsa, Inc., a Vifor Pharma Company, today announced five posters, including new analyses from studies of Veltassa® (patiromer) for oral suspension and new data on the impact of hyperkalemia, will be...

Performance

More News

Galenica completes acquisition of Relypsa, strengthening Vifor Pharma's position in cardio-renal therapies

September 01, 2016

Galenica announces Expiration of Cash Tender Offer for Shares of Common Stock of Relypsa

August 31, 2016

Scientist.com Raises $24M to Expand Next Generation Pharmaceutical Outsourcing Marketplace

May 15, 2017

Relypsa Announces Phase 4 Study Shows Veltassa® Demonstrated Similar Efficacy and Safety Whether Given With or Without Food in Patients with Hyperkalemia

August 30, 2016

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Relypsa, Inc. (RLYP)

August 15, 2016

The 7 Biggest Market Rumors Of 2016: Where Are They Now?

December 21, 2016

BRIEF-Galenica says 85.6 pct of Relypsa shares tendered

August 31, 2016

BRIEF-Relypsa says Phase 4 TOURMALINE study meets primary endpoint

August 30, 2016

Watch These 7 Huge Call Purchases In Wednesday Trade

August 23, 2016

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.